✦ LIBER ✦

Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine

✍ Scribed by David J Moliterno; Debabrata Mukherjee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dosing considerations and monitoring of

✍ Chidambaram Rammohan; Dan Fintel 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 251 KB

Glycoprotein IIb/IIIa inhibitors and low

✍ EDWARD T. A. Fry 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Inhibition of Tissue Factor-Activated Pl

✍ Sarfraz Ahmad; Walter P. Jeske; Qing Ma; Jeanine M. Walenga; Jawed Fareed 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Safety and effectiveness of combined low

✍ David Kovar; John G Canto; William J Rogers 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Pharmacokinetics and Pharmacodynamics of

✍ Brian S. Smith; Pritesh J. Gandhi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 114 KB

Use of Low Molecular Weight Heparins and

✍ Mark A. Perazella; Ari Mosenkis; Jeffrey S. Berns 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB